SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the September 2021 quarter moved up 34.00% to Rs. 1223.08 millions as compared to Rs. 912.78 millions during the corresponding quarter last year.The Company has registered profit of Rs. 174.71  millions for the quarter ended September 2021, a growth of 14.77%  over Rs. 152.23 millions millions achieved in the corresponding quarter of last year.The company reported a good operating profit of 275.34 millions compared to 229.56 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202109 202009 % Var
Sales 1223.08 912.78 34.00 1223.08 912.78 34.00 1223.08 912.78 34.00
Other Income 1.63 10.91 -85.06 1.63 10.91 -85.06 1.63 10.91 -85.06
PBIDT 275.34 229.56 19.94 275.34 229.56 19.94 275.34 229.56 19.94
Interest 26.92 14.03 91.87 26.92 14.03 91.87 26.92 14.03 91.87
PBDT 248.42 215.53 15.26 248.42 215.53 15.26 248.42 215.53 15.26
Depreciation 23.18 11.31 104.95 23.18 11.31 104.95 23.18 11.31 104.95
PBT 225.24 204.22 10.29 225.24 204.22 10.29 225.24 204.22 10.29
TAX 50.53 51.99 -2.81 50.53 51.99 -2.81 50.53 51.99 -2.81
Deferred Tax 7.06 1.55 355.48 7.06 1.55 355.48 7.06 1.55 355.48
PAT 174.71 152.23 14.77 174.71 152.23 14.77 174.71 152.23 14.77
Equity 364.37 105.00 247.02 364.37 105.00 247.02 364.37 105.00 247.02
PBIDTM(%) 22.51 25.15 -10.49 22.51 25.15 -10.49 22.51 25.15 -10.49

Acutaas Chemicals Share Price

2361.75 16.10 (0.69%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×